(Q43474405)

23 November 2017

title

Device-related complications of long-term intrathecal drug therapy via implanted pumps (English)

1 reference

23 November 2017

B Flückiger

1

1 reference

23 November 2017

H Knecht

series ordinal

2

1 reference

23 November 2017

S Grossmann

series ordinal

3

1 reference

23 November 2017

P Felleiter

series ordinal

4

1 reference

23 November 2017

publication date

11 March 2008

1 reference

23 November 2017

1 reference

23 November 2017

volume

46

1 reference

23 November 2017

issue

9

1 reference

23 November 2017

page(s)

639-643

1 reference

Reduced spinal reflexes following intrathecal baclofen in the rabbit

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSC.2008.24

Intrathecal baclofen in tetraplegia of spinal origin: efficacy for upper extremity hypertonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSC.2008.24

Long-term safety and efficacy of continuous intrathecal baclofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSC.2008.24

Treatment of spasticity with intrathecal Baclofen administration: long-term follow-up, review of 40 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSC.2008.24

Programmable intrathecal opioid delivery systems for chronic noncancer pain: a systematic review of effectiveness and complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSC.2008.24

Intrathecal baclofen for the treatment of intractable spasticity of spine or brain etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSC.2008.24

Response of intractable pain to continuous intrathecal morphine: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSC.2008.24

A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSC.2008.24

Pain Relief by Intrathecally Applied Morphine in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSC.2008.24

7 January 2021

Intrathecal baclofen for spasticity of spinal origin: seven years of experience

1 reference

https://api.crossref.org/works/10.1038%2FSC.2008.24

7 January 2021

Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity.

1 reference

https://api.crossref.org/works/10.1038%2FSC.2008.24

7 January 2021

Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study

1 reference

https://api.crossref.org/works/10.1038%2FSC.2008.24

7 January 2021

Complications of intrathecal baclofen delivery

1 reference

https://api.crossref.org/works/10.1038%2FSC.2008.24

7 January 2021

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

1 reference

https://api.crossref.org/works/10.1038%2FSC.2008.24

7 January 2021

Treatment of chronic pain by using intrathecal drug therapy compared with conventional pain therapies: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1038%2FSC.2008.24

7 January 2021

Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology

1 reference

https://api.crossref.org/works/10.1038%2FSC.2008.24

7 January 2021

Identifiers

DOI

10.1038/SC.2008.24

1 reference

23 November 2017

1 reference